News
Posted: October 31, 2018 | News, Press
AMSINO CLOSED THE ASSET PURCHASE AGREEMENT TO ACQUIRE SMITHS MEDICAL’S VERNON HILL’S PLANT
Pomona, CA —Amsino Medical Group is pleased to announce the closing of the previously announced Asset Purchase Agreement today with Smiths Medical ASD, Inc. (Smiths) to acquire the assets of Smiths’ manufacturing plant located in Vernon Hills, Illinois (VH). The transaction includes all assets and infrastructure that currently exist in the facility.
The plant is an FDA registered pharmaceutical manufacturer of essential inhalation therapy, wound care and other USP grade saline/water based products for the medical device and pharmaceutical industries.
“The acquisition is in alignment with Amsino’s strategic global expansion goals and its mission to improve the safety and efficacy of patient care worldwide. We look forward to expanding the current business and becoming the ‘go-to’ company for USP grade water and saline based products for the global medical device and pharmaceutical industry” said Dr. Richard Lee, Chairman and CEO of Amsino.
This acquisition positions Amsino for significant growth as it enters new markets with expanded product offering.
About Amsino Medical Group
Established in 1993 and headquartered in the U.S., Amsino develops, manufactures and markets medical devices that help improve the safety and efficacy of patient care under a portfolio of globally recognized Amsino brands. The company operates several U.S. FDA qualified manufacturing and R&D facilities globally under ISO13485 quality management system. Visit www.amsino.com for more information.
CONTACT:
Center of Excellence
Communications Manager
(909) 626-5888